The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis

Ahmadikia, Kazem; Jamal Hashemi, Seyed; Khodavaisy, Sadegh; Ibrahim Getso, Muhammad; Alijani, Neda; Badali, Hamid; Mirhendi, Hossein; Salehi, Mohammadreza; Tabari, Azin; Mohammadi Ardehali, Mojtaba; Kord, Mohammad; Roilides, Emmanuel; Rezaie, Sassan

doi:10.1111/myc.13256

Public

The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis

Published in Mycoses • Feb 17, 2021

Authors:

Kazem Ahmadikia

Seyed Jamal Hashemi

Sadegh Khodavaisy

Abstract

Acute respiratory distress syndrome is a common complication of severe viral pneumonia, such as influenza and COVID-19, that requires critical care including ventilatory support, use of corticosteroids and other adjunctive therapies to arrest the attendant massive airways inflammation. Although reco...

Subject

Mucormycosis

Pneumonia

Coronavirus disease 2019 (COVID-19)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!